Hypertrophic Cardiomyopathy With Left Ventricular Systolic Dysfunction: Insights From the SHaRe Registry

The term “end stage” has been used to describe hypertrophic cardiomyopathy (HCM) with left ventricular systolic dysfunction (LVSD), defined as occurring when left ventricular ejection fraction is <50%. The prognosis of HCM-LVSD has reportedly been poor, but because of its relative rarity, the nat...

Volledige beschrijving

Bewaard in:
Bibliografische gegevens
Gepubliceerd in:Circulation
Hoofdauteurs: Marstrand, Peter, Han, Larry, Day, Sharlene M., Olivotto, Iacopo, Ashley, Euan A., Michels, Michelle, Pereira, Alexandre C., Wittekind, Samuel G., Helms, Adam, Saberi, Sara, Jacoby, Daniel, Ware, James S., Colan, Steven D., Semsarian, Christopher, Ingles, Jodie, Lakdawala, Neal K., Ho, Carolyn Y.
Formaat: Artigo
Taal:Inglês
Gepubliceerd in: Lippincott Williams & Wilkins 2020
Onderwerpen:
Original Research Articles
Online toegang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7182243/
https://ncbi.nlm.nih.gov/pubmed/32228044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/CIRCULATIONAHA.119.044366
Tags: Voeg label toe
Geen labels, Wees de eerste die dit record labelt!

Gelijkaardige items